<p>Guideline-adherent care is associated with better patient outcomes, but whether this can be achieved by professional education is unclear. Here we conducted a cluster-randomized controlled trial across 70 centers in six countries to understand if a program for the education of healthcare professionals could improve patient-level adherence to clinical practice guidelines on atrial fibrillation (AF). Each center recruited patients with AF seen in routine practice (total <i>N</i> = 1,732), after which the centers were randomized, accounting for baseline guideline adherence to class I and III recommendations from the European Society of Cardiology on stroke prevention and rhythm control. Healthcare professionals in the intervention centers received a 16-week structured educational program with an average of 9 h of online engagement, whereas those at control centers received no additional education beyond standard practice. For the co-primary stroke prevention outcome, guideline adherence was 63.4% and 58.6% at baseline and 67.5% and 60.9% at 6–9-months follow-up for the intervention and control groups, respectively (adjusted risk ratio 1.10; 95% confidence interval (CI) 0.97 to 1.24; <i>P</i> = 0.13). For the co-primary rhythm control outcome, guideline adherence was 21.4% and 20.4% at baseline and 33.9% and 22.9% at follow-up for the intervention and control groups, respectively (adjusted risk ratio 1.51; 95% CI 1.04 to 2.18; <i>P</i> = 0.03). The secondary outcome of patient-reported integrated AF management showed a 5.1% improvement in the intervention group compared with the control group (95% CI 1.4% to 8.9%; <i>P</i> = 0.01). Thus, while the education of healthcare professionals improved substantial gaps in implementation for rhythm control, it had no significant effect on stroke prevention. ClinicalTrials.gov registration: <a href="https://clinicaltrials.gov/study/NCT04396418">NCT04396418</a>.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Education of healthcare professionals to improve guideline adherence in atrial fibrillation: the STEEER-AF cluster-randomized clinical trial

  • Dipak Kotecha,
  • Karina V. Bunting,
  • Samir Mehta,
  • Philipp Sommer,
  • Maciej Sterliński,
  • Kim Rajappan,
  • Lluís Mont,
  • Eduard Guasch,
  • Serge Boveda,
  • Giuseppe Boriani,
  • Yongzhong Sun,
  • Colinda van Deutekom,
  • Chris P. Gale,
  • Tom J. R. De Potter,
  • Isabelle C. van Gelder,
  • Yann Allali,
  • Asgher Champsi,
  • Thomas Deneke,
  • Kaitlyn Greeley,
  • Benoît Guy-Moyat,
  • Mikael Laredo,
  • Alastair Mobley,
  • Maximina Ventura,
  • Mary Stanbury,
  • Trudie Lobban,
  • Thompson Robinson,
  • Tatjana Potpara,
  • Eloi Marijon,
  • Pascal Defaye,
  • Pierre Baudinaud,
  • Simon Kochhaeuser,
  • Ursula Rauch,
  • Moritz F. Sinner,
  • Marco Proietti,
  • Igor Diemberger,
  • Vincenzo Russo,
  • Stanislaw Tubek,
  • Piotr Buchta,
  • Pawel Balsam,
  • Eusebio García-Izquierdo,
  • Ivo Roca Luque,
  • Jose M. Guerra,
  • Dewi Thomas,
  • Afzal Sohaib,
  • Mark J. Davies,
  • Olivier Piot,
  • William Escande,
  • Christian De Chillou,
  • Maxime De Guillebon,
  • Frédéric Anselme,
  • Andrea Cianci,
  • Rodrigue Garcia,
  • Philippe Maury,
  • Dominique Pavin,
  • Estelle Gandjbakhch,
  • Frédéric Sacher,
  • Karim Hasni,
  • Fabien Garnier,
  • Charles Guenancia,
  • Nicolas Lellouche,
  • Stephan Willems,
  • Martin Borlich,
  • Andreas Metzner,
  • Hans-Holger Ebert,
  • Dong-In Shin,
  • David Duncker,
  • Stefan G. Spitzer,
  • Peter Nordbeck,
  • Roland R. Tilz,
  • Andrea Mazza,
  • Cinzia Valzania,
  • Margherita Padeletti,
  • Matteo Bertini,
  • Jacopo F. Imberti,
  • Stefano Fumagalli,
  • Antonio Rapacciuolo,
  • Monika Lica Gorzynska,
  • Adam Gorlo,
  • Marcin Kostkiewicz,
  • Grzegorz Sobieszek,
  • Andrzej S. Skrzyński,
  • Robert Gajda,
  • Hanna Wilk-Manowiec,
  • Jaroslaw Blicharz,
  • Wiktor K. Gmiński,
  • Tomasz Czerski,
  • Felipe Bisbal,
  • Ignasi Anguera,
  • Teresa Lozano,
  • Joaquin Osca,
  • Jose L. Merino,
  • Naiara Calvo,
  • Juan Fernández-Armenta,
  • Juan Acosta,
  • Nuria Rivas-Gandara,
  • Pilar Cabanas-Grandío,
  • Emilce Trucco,
  • Richard Bond,
  • Richard Ang,
  • Shawn A. A. Morais,
  • Fu Siong Ng,
  • Matthew G. D. Bates,
  • Michala Pedersen,
  • Daniel T. Raine,
  • Manish Kalla,
  • Matthew J. Lovell,
  • Malcolm Finlay,
  • Arif Hasan Bhuiyan,
  • Norman Qureshi,
  • Hein Heidbuchel,
  • Wolfram Döhner,
  • Bernard Iung,
  • Susanna Price,
  • Helmut Pürerfellner,
  • Barbara Casadei,
  • Alex R. Lyon,
  • Winston Banya,
  • Robert Hatala,
  • Pekka Raatikainen,
  • Paulus Kirchhof

摘要

Guideline-adherent care is associated with better patient outcomes, but whether this can be achieved by professional education is unclear. Here we conducted a cluster-randomized controlled trial across 70 centers in six countries to understand if a program for the education of healthcare professionals could improve patient-level adherence to clinical practice guidelines on atrial fibrillation (AF). Each center recruited patients with AF seen in routine practice (total N = 1,732), after which the centers were randomized, accounting for baseline guideline adherence to class I and III recommendations from the European Society of Cardiology on stroke prevention and rhythm control. Healthcare professionals in the intervention centers received a 16-week structured educational program with an average of 9 h of online engagement, whereas those at control centers received no additional education beyond standard practice. For the co-primary stroke prevention outcome, guideline adherence was 63.4% and 58.6% at baseline and 67.5% and 60.9% at 6–9-months follow-up for the intervention and control groups, respectively (adjusted risk ratio 1.10; 95% confidence interval (CI) 0.97 to 1.24; P = 0.13). For the co-primary rhythm control outcome, guideline adherence was 21.4% and 20.4% at baseline and 33.9% and 22.9% at follow-up for the intervention and control groups, respectively (adjusted risk ratio 1.51; 95% CI 1.04 to 2.18; P = 0.03). The secondary outcome of patient-reported integrated AF management showed a 5.1% improvement in the intervention group compared with the control group (95% CI 1.4% to 8.9%; P = 0.01). Thus, while the education of healthcare professionals improved substantial gaps in implementation for rhythm control, it had no significant effect on stroke prevention. ClinicalTrials.gov registration: NCT04396418.